Crossmark

Dasatinib Cube-O-Needle hybrid system for effective and safe site-specific treatment for triple-negative breast cancer

Published Online: 2026-04-01

Authors

Rana, Hardik

Patel, Shachi

Thakkar, Vaishali

Gandhi, Tejal
License Information

Text and Data Mining valid from 2026-04-01

Version of Record valid from 2026-04-01
More Information

Article History

Received: 10 February 2026

Accepted: 24 March 2026

First Online: 1 April 2026

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

: Not applicable.

Document is current